Additional Policy and Advocacy Engagement
Check out more of SWHR’s efforts to bolster women’s health across the federal government.
SWHR regularly engages with members of Congress and congressional staff, the administration, and independent entities to raise awareness about diseases, conditions, and life stages that differently or disproportionately impact women as well as considerations specific to women that can be taken into account during policy development.
SWHR highlights the need for comprehensive legislative action to increase patient access to high-quality health care and treatments for women...
SWHR submitted feedback in response to a call for input from Representatives DeGette and Bucshon on the Next-Generation Cures bill.
SWHR joined more than 200 national organizations in a letter to House appropriators expressing concern over including a proposal to...
SWHR sent a letter to the House Ways & Means Committee expressing support for the Committee's expected June markup of...
Nearly 30 organizations sent a letter to CMS Administrator Brooks-LaSure and White House Initiative on Women's Health Research Chair Dr....
SWHR submitted outside witness testimony to the House and Senate Labor-HHS Appropriations Subcommittees outlining its funding requests for fiscal year...
SWHR, American Heart Association, and 20 national organizations sent a letter to Sens. Hyde-Smith and Peters thanking them for introducing...
The Society for Women’s Health Research (SWHR) sent a letter to Dr. Carolyn Mazure, Chair of the White House Initiative...
The Society for Women’s Health Research (SWHR) sent a letter congratulating Monica Bertagnolli, MD, on her confirmation as Director of...
The Society for Women’s Health Research (SWHR) responded to a September 2023 request for information from Senate Health, Education, Labor,...
Sixteen national organizations joined a sign-on letter led by the American Heart Association and the Society for Women’s Health Research...
The Society for Women’s Health Research sent a letter thanking the Co-Chairs and Co-Vice Chairs of the Bipartisan Women’s Caucus...
The Society for Women’s Health Research submitted comments to the Institute for Clinical and Economic Review (ICER) on its Methods...
SWHR submitted outside witness testimony to the House Labor, Health and Human Services, Education and Related Agencies Appropriations Subcommittee with...
SWHR provided feedback to the Institute for Clinical and Economic Review (ICER) in response to its Draft Evidence Report assessing...
The Society for Women’s Health Research (SWHR) sent a letter to House and Senate leadership urging both chambers to come...
The Society for Women’s Health Research sent a letter to the Institute for Clinical and Economic Review (ICER) in response...
The Society for Women’s Health Research provided public comments on October 18, 2022 during the National Center for Complementary and...
The Society for Women’s Health Research sent a letter to Monica M. Bertagnolli, MD, welcoming her to her new role...
In response to the White House’s call for ideas and stories related to the Fall 2022 Conference on Hunger, Nutrition,...
SWHR sent a letter to the Institute for Clinical and Economic Review (ICER) over its draft scoping document related to...
The Society for Women’s Health Research submitted outside witness testimony to the Senate Labor, Health and Human Services, Education and...
The Society for Women’s Health Research provided feedback to the Innovation and Value Initiative on the draft protocol of its...
SWHR President & CEO Kathryn G. Schubert submitted comments to Representatives Diana DeGette and Fred Upton in response to the...
The Society for Women’s Health Research (SWHR) joined Trust for America’s Health and more than 200 other organizations in the...
In a letter to the Institute for Clinical and Economic Review (ICER), SWHR expressed concern over the methodology and conclusions...
SWHR signed on to letters to Labor HHS Subcommittee leadership in the House and Senate with requests for the fiscal...
SWHR sent a letter urging Secretary of Health and Human Services (HHS) Xavier Becerra to prioritize the important work of...
SWHR signed on to a letter urging Congressional leadership to include investments in the infrastructure underpinning the medical research enterprise...
As part of our efforts to support the National Institutes of Health (NIH) and to advance women’s health research, SWHR...
SWHR sent a letter to Andrea Palm to congratulate her on her recent confirmation as Deputy Secretary for Health at...
SWHR President & CEO Kathryn G. Schubert submitted comments to the Innovation and Value Initiative (IVI) in response to their...
SWHR signed on to a letter urging Congress to provide $100 million for the Surveillance for Emerging Threats to Mothers...
SWHR President & CEO Kathryn G. Schubert submitted comments to the National Institutes of Health UNITE Initiative Committees in response...
SWHR sent a letter to Xavier Becerra to congratulate him on his recent appointment as Secretary at the Department of...
SWHR sent a letter to Dr. Rachel Levine to congratulate her on her recent appointment as Assistant Secretary for Health...
SWHR signed on to a letter, led by Research!America, encouraging President Joe Biden to champion the Research Investment to Spark...
SWHR signed on to a letter urging Congress to support at least $750 million for the Title V Maternal and...
SWHR President and CEO Kathryn G. Schubert sent a letter to Congressional leadership on the House and Senate Appropriations Subcommittees...
SWHR sent a letter to Dr. Rochelle Walensky to congratulate her on her recent appointment as Director of the Centers...
SWHR signed onto a letter thanking the Advisory Committee on Immunization Practices (ACIP) at the Centers for Disease Control and...
This week, SWHR President and CEO Kathryn G. Schubert submitted testimony for the record to the House Energy & Commerce...
SWHR signed onto a letter urging Congress to include no less than $500 million in funding for the Agency for...
The Society for Women’s Health Research sent a letter to President Joe Biden, thanking him for his recent appoint of...
SWHR signed onto a letter with more than 170 organizations and institutions urging swift action to complete work on fiscal...
SWHR and nearly 350 other organizations signed onto a letter to President-Elect Biden discussing the importance of federal investment in...
In a push to see maternal health bills included in a year-end legislative package, SWHR signed onto a letter urging...
SWHR joined more than 75 organizations in calling for strong funding for government public health and biomedical research agencies for...
SWHR sent a letter to Congressional leadership in support of endometriosis’ inclusion as an eligible condition under the Department of...
SWHR provided open input to the Institute for Clinical and Economic Review (ICER) on contextual considerations surrounding Alzheimer’s disease and...
SWHR provided comments in response to the NAM “Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine...
SWHR and 95 other organizations signed on to a letter endorsing a bill to direct AHRQ to conduct or support...
SWHR thanks HHS for renewing the public health emergency declaration for the COVID-19 pandemic as urged in a previous sign-on...
SWHR signed on to a letter to Senate leadership requesting $100 million for the Surveillance for Emerging Threats to Moms...
SWHR signed on to a letter urging Congressional leadership to include H.R. 4996, the Helping MOMS Act, in forthcoming COVID-19...
SWHR and 279 other organizations called on HHS Secretary Alex Azar to address racial disparities and years of structural racism...
SWHR signed on to a recent letter urging HHS to renew the public health emergency declaration for COVID-19 before it...
SWHR applauds the work of the PRGLAC task force in advising HHS on best practices to lessen knowledge gaps regarding safe...
SWHR signed onto a congressional letter of support for H.R. 6383, the Uterine Fibroid Research and Education Act of 2020.
SWHR stresses the importance of sex and gender as factors in pandemic response and preparedness in feedback on a Senate...
SWHR joined 25 organizations in urging the FDA and NIH to include certain groups of at-risk women in prioritized federal...
SWHR CEO Kathryn G. Schubert provided testimony to the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and...
SWHR provided Congress with initial feedback today in response to the recent concept paper addressing the bipartisan planned “Cures 2.0”...
SWHR urged the NIH and FDA to include pregnant women and lactating women in all research for the development of...
SWHR sent comments to the Senate Finance Subcommittee on Health Care in response to the its call for feedback related...
In a letter to the White House Office of Science and Technology Policy (OSTP), SWHR recommended the government prioritize biotechnology...
SWHR provided recommendations to the Institute for Clinical and Economic Review (ICER) on proposed changes to its 2020 value assessment...
SWHR provided input to the Institute for Clinical and Economic Review (ICER) on the 2020 update to its value assessment...
In a letter to the Secretary of Health and Human Services, SWHR expresses its concerns about the future status of...
SWHR sent letters to the Senate and House subcommittees that oversee National Institutes of Health (NIH) funding urging increased investment...
SWHR sends letter to Sen. Duckworth (D-IL) and Rep. Schakowsky (D-IL-09) in acknowledgment of their resolutions recognizing Women’s Health Research...
SWHR joined a stakeholder letter to Congress calling for continued prioritization of diagnostic reform regarding LDTs and in vitro diagnostics.
SWHR provided comments to the Institute for Clinical and Economic Review (ICER) on its draft report assessing new endometriosis therapies.
SWHR and stakeholder coalition send letter to Congressional committee leadership, focusing on the need for oversight for clinical laboratory diagnostics.
SWHR commented on ICER's migraine therapies draft report, regarding the effectiveness and value of calcitonin gene-related peptide (CGRP) inhibitors.
On February 1, 2018, SWHR submitted comments to the Institute for Clinical and Economic Review (ICER) before its assessment of...
SWHR praises Sen. Duckworth and Rep. Schakowsky for their efforts in supporting Women's Health Research Day on January 25.
SWHR urged the Institute for Clinical and Economic Review (ICER) to incorporate the significant burden of migraine into its assessment...
SWHR issued a letter supporting the continuation of the FDA user fee programs in order to guarantee sufficient scientific capacity...
Check out more of SWHR’s efforts to bolster women’s health across the federal government.